ALTHUARDE LIFE SCIENCES
ALTHUARDE LIFE SCIENCES is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €126k and a net result of €26k. Equity is growing by ~39.6% per year across the filed fiscal years. Its solvency ranks better than 51% of 3146 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €126k |
| Net result | €26k |
| Better than sector | 51% |
| Active | 4 yrs |
Strong profile, led by profitability.
Computed on 4 of 5 axes. Not measured: health. An unmeasured axis is not a zero: no data was read for it.
This is a financial institution (bank, insurer or financial holding). Our bankruptcy model is trained on ordinary trading and manufacturing companies; a bank balance sheet falls outside that scope. We therefore show no bankruptcy probability rather than a misleading figure.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 53.1% | 52.5% | |
| Net result | €26k | €32k | |
| Equity | €126k | €75k | |
| Gross operating margin | €55k | €52k | |
| Total assets | €238k | €192k |
Show 2 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | n/a |
| EBITDA | n/a |
| Net profit | €26k |
| Cash flow | n/a |
| Staff costs | - |
| Income taxes | €7k |
| Dividends | - |
| Total assets | €238k |
| Equity | €126k |
| Debt | €112k |
| of which ≤ 1y | €54k |
| of which > 1y | €58k |
| Working capital | n/a |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | n/a |
| Quick ratio | n/a |
| Working capital ratio | n/a |
| Solvency | 53.1% |
| Debt / equity | n/a |
| Long-term debt ratio | n/a |
| Interest coverage | n/a |
| Gross margin | n/a |
| Net margin | n/a |
| ROA | 11.0% |
| ROE | 20.6% |
| EBITDA margin | n/a |
| Days sales outstanding | n/a |
| Days payable outstanding | n/a |
| Inventory turnover | n/a |
| Days inventory (DSI) | n/a |
Full annual accounts (21 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €238k |
| Fixed assets | 21/28 | €171k |
| Tangible fixed assets | 22/27 | €171k |
| Current assets | 29/58 | €67k |
| Cash & bank | 54/58 | €29k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €238k |
| Equity | 10/15 | €126k |
| Contributions / capital | 10/11 | €5k |
| Accumulated profits (losses) | 14 | €121k |
| Amounts payable | 17/49 | €112k |
| Amounts payable after one year | 17 | €58k |
| Amounts payable within one year | 42/48 | €54k |
| Trade debts payable within one year | 44 | €4k |
| Income statement | ||
| Gross operating margin | 9900 | €55k |
| Operating result | 9901 | €38k |
| Financial income | 75 | €660 |
| Financial charges | 65 | €5k |
| Result before taxes | 9903 | €33k |
| Income taxes | 67/77 | €7k |
| Net result for the period | 9904 | €26k |
| Result to be appropriated | 9905 | €26k |
| NACE primary | Activiteiten van holdings(64210) |
| Legal form | Private limited company(610) |
| Incorporation | 09-12-2021 |
| Status | Active |
| Postal code | 3321 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24087E0549/00V000 | Flanders | 1,696 m² | 1 · 351 m² | 14.0 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
07-08-2026 Act object · Notarial deed · General meeting · Capital increase
- Act object: ONTSLAGEN, BENOEMINGEN, KAPITAAL, AANDELEN · SPICA THERAPEUTICS
- Publication: 07/08/2026 · SPICA THERAPEUTICS
- Filing: 05-08-2026 · SPICA THERAPEUTICS
- Notarial deed: 29-07-2026 · SPICA THERAPEUTICS
- General meeting: 29-07-2026 · SPICA THERAPEUTICS
- Capital increase: after: 14.987.251,44 EUR, delta: 4.100.000,00 EUR, amount: 14987251.44, before: 10.887.251,44 EUR, paid_up: 100%, payment: in geld, currency: EUR, shares_issued: 83.128 Seed aandelen · SPICA THERAPEUTICS
- Bank account: bank: BNP Paribas Fortis, date: 27 juli 2026, number: BE35 0020 3420 0437 · SPICA THERAPEUTICS
- Capital: amount: 14987251.44, currency: EUR, shares_total: 318.982 · SPICA THERAPEUTICS
- Share issue: type: Anti-Dilutie Inschrijvingsrechten, count: 15, description: Full Seed anti-dilutie Inschrijvingsrechten · SPICA THERAPEUTICS
- Capital increase: type: conditional, shares: Seed Aandelen, currency: EUR, condition: uitoefening van de anti-dilutie Inschrijvingsrechten, max_amount: vermenigvuldiging van het aantal uitgeoefende Full Seed anti-dilutie Inschrijvingsrechten met de uitoefeningsprijs · SPICA THERAPEUTICS
- Share issue: plan: Aandelenoptieplan 2026 BIS, type: ESOP Inschrijvingsrechten, count: 24.717, description: ESOP 2026 BIS Inschrijvingsrechten · SPICA THERAPEUTICS
- Capital increase: type: conditional, shares: maximaal 24.717 Gewone Aandelen, currency: EUR, condition: uitoefening van de 2026 BIS ESOP Inschrijvingsrechten, max_amount: vermenigvuldiging van het aantal uitgeoefende 2026 BIS ESOP Inschrijvingsrechten met de uitoefeningsprijs · SPICA THERAPEUTICS
- Officer resignation: role: bestuurder · Impala Consulting Comm.V
- Officer appointment: role: bestuurder, term: 6 jaar, start_date: 2026-07-29 · ALTHUARDE LIFE SCIENCES
- Permanent representative: role: Investeerder Bestuurder · Roderick Verhelst
- Mandate compensation: onbezoldigd · ALTHUARDE LIFE SCIENCES
- Subscription right cancellation: type: Anti-Dilutie Inschrijvingsrechten, count: 15, status: niet-toegekend, issued_date: 27 mei 2025 · SPICA THERAPEUTICS
- Subscription right cancellation: type: ESOP Inschrijvingsrechten, count: 15.481, status: niet-toegekend · SPICA THERAPEUTICS
- Board authorization: plan: Aandelenoptieplan 2026 BIS, scope: vaststelling identiteit begunstigden, aantal aangeboden 2026 BIS ESOP Inschrijvingsrechten en uitoefenprijs, mandatary: raad van bestuur · SPICA THERAPEUTICS
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte : ONTSLAGEN, BENOEMINGEN, KAPITAAL, AANDELEN",
"value": "ONTSLAGEN, BENOEMINGEN, KAPITAAL, AANDELEN",
"object": null,
"subject": "e1"
},
{
"date": "2026-08-07",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 07/08/2026",
"value": "07/08/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-08-05",
"type": "filing",
"quote": "Neergelegd 05-08-2026",
"value": "05-08-2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-29",
"type": "notarial_deed",
"quote": "Op heden, negenentwintig juli tweeduizend zesentwintig. (...) Voor Tim CARNEWAL, notaris te Brussel",
"value": "29-07-2026",
"object": "e6",
"subject": "e1"
},
{
"date": "2026-07-29",
"type": "general_meeting",
"quote": "Op heden, negenentwintig juli tweeduizend zesentwintig. (...) WORDT GEHOUDEN de buitengewone algemene vergadering",
"value": "29-07-2026",
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 4.100.000,00 EUR, om het van 10.887.251,44 EUR te brengen op 14.987.251,44 EUR, door inbreng in geld en met de uitgifte van 83.128 Seed aandelen",
"value": {
"after": "14.987.251,44 EUR",
"delta": "4.100.000,00 EUR",
"amount": 14987251.44,
"before": "10.887.251,44 EUR",
"paid_up": "100%",
"payment": "in geld",
"currency": "EUR",
"shares_issued": "83.128 Seed aandelen"
},
"amount": 4100000.0,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"after": "14.987.251,44 EUR",
"delta": "4.100.000,00 EUR",
"before": "10.887.251,44 EUR",
"paid_up": "100%",
"payment": "in geld",
"shares_issued": "83.128 Seed aandelen"
}
},
{
"date": "2026-07-27",
"type": "bank_account",
"quote": "gestort op een bijzondere rekening met nummer BE35 0020 3420 0437 op naam van de Vennootschap bij BNP Paribas Fortis, zoals blijkt uit een attest afgeleverd door deze kredietinstelling op 27 juli 2026",
"value": {
"bank": "BNP Paribas Fortis",
"date": "27 juli 2026",
"number": "BE35 0020 3420 0437"
},
"object": null,
"subject": "e1"
},
{
"type": "capital",
"quote": "Het kapitaal van de vennootschap bedraagt veertien miljoen negenhonderdzevenentachtigduizend tweehonderdeenenvijftig euro vierenveertig cent (14.987.251,44 EUR). ... vertegenwoordigd door driehonderd achttienduizend negenhonderd twee\u00EBntachtig (318.982) aandelen ... waarvan: - honderdveertienduizend tweehonderdenvijf (114.205) Gewone Aandelen; en - tweehonderdvierduizend zevenhonderd zevenenzeventig (204.777) Seed Aandelen.",
"value": {
"amount": 14987251.44,
"currency": "EUR",
"breakdown": [
"114.205 Gewone Aandelen",
"204.777 Seed Aandelen"
],
"shares_total": "318.982"
},
"amount": 14987251.44,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"amount": "14.987.251,44 EUR",
"breakdown": [
"114.205 Gewone Aandelen",
"204.777 Seed Aandelen"
],
"shares_total": "318.982"
}
},
{
"type": "share_issue",
"quote": "De vergadering beslist 15 Full Seed anti-dilutie Inschrijvingsrechten uit te geven",
"value": {
"type": "Anti-Dilutie Inschrijvingsrechten",
"count": "15",
"description": "Full Seed anti-dilutie Inschrijvingsrechten"
},
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "De vergadering beslist - onder de opschortende voorwaarde en in de mate van de uitoefening van de anti-dilutie Inschrijvingsrechten \u2013 over te gaan tot een kapitaalverhoging in geld",
"value": {
"type": "conditional",
"shares": "Seed Aandelen",
"currency": "EUR",
"condition": "uitoefening van de anti-dilutie Inschrijvingsrechten",
"max_amount": "vermenigvuldiging van het aantal uitgeoefende Full Seed anti-dilutie Inschrijvingsrechten met de uitoefeningsprijs"
},
"object": null,
"subject": "e1",
"_value_raw": {
"type": "conditional",
"shares": "Seed Aandelen",
"condition": "uitoefening van de anti-dilutie Inschrijvingsrechten",
"max_amount": "vermenigvuldiging van het aantal uitgeoefende Full Seed anti-dilutie Inschrijvingsrechten met de uitoefeningsprijs"
}
},
{
"type": "share_issue",
"quote": "De vergadering beslist 24.717 ESOP 2026 BIS Inschrijvingsrechten uit te geven in het kader van het \u201CAandelenoptieplan 2026 BIS\u201D",
"value": {
"plan": "Aandelenoptieplan 2026 BIS",
"type": "ESOP Inschrijvingsrechten",
"count": "24.717",
"description": "ESOP 2026 BIS Inschrijvingsrechten"
},
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "De vergadering beslist - onder de opschortende voorwaarde en in de mate van de uitoefening van de 2026 BIS ESOP Inschrijvingsrechten \u2013 over te gaan tot een kapitaalverhoging in geld ... met uitgifte van maximaal 24.717 Gewone Aandelen",
"value": {
"type": "conditional",
"shares": "maximaal 24.717 Gewone Aandelen",
"currency": "EUR",
"condition": "uitoefening van de 2026 BIS ESOP Inschrijvingsrechten",
"max_amount": "vermenigvuldiging van het aantal uitgeoefende 2026 BIS ESOP Inschrijvingsrechten met de uitoefeningsprijs"
},
"object": null,
"subject": "e1",
"_value_raw": {
"type": "conditional",
"shares": "maximaal 24.717 Gewone Aandelen",
"condition": "uitoefening van de 2026 BIS ESOP Inschrijvingsrechten",
"max_amount": "vermenigvuldiging van het aantal uitgeoefende 2026 BIS ESOP Inschrijvingsrechten met de uitoefeningsprijs"
}
},
{
"type": "officer_resignation",
"quote": "De vergadering neemt kennis van en aanvaardt het ontslag van de volgende bestuurder: - Impala Consulting Comm.V, vertegenwoordigd door Alexander Demoulin",
"value": {
"role": "bestuurder"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "bestuurder",
"representative": "Alexander Demoulin"
}
},
{
"date": "2026-07-29",
"type": "officer_appointment",
"quote": "De vergadering beslist om te benoemen tot bestuurder en dit voor een termijn van 6 jaar: - De besloten vennootschap \u201CALTHUARDE LIFE SCIENCES\u201D",
"value": {
"role": "bestuurder",
"term": "6 jaar",
"start_date": "2026-07-29"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "bestuurder",
"term": "6 jaar",
"start_date": "29-07-2026"
}
},
{
"type": "permanent_representative",
"quote": "ALTHUARDE LIFE SCIENCES ... vast vertegenwoordigd door de heer Roderick Verhelst ... als Investeerder Bestuurder",
"value": {
"role": "Investeerder Bestuurder"
},
"object": "e4",
"subject": "e5"
},
{
"type": "mandate_compensation",
"quote": "Hun mandaat zal onbezoldigd zijn.",
"value": "onbezoldigd",
"object": null,
"subject": "e4"
},
{
"type": "subscription_right_cancellation",
"quote": "De vergadering beslist tot vernietiging van 15 anti-dilutie inschrijvingsrechten uitgegeven door de buitengewone algemene vergadering van de Vennootschap van 27 mei 2025",
"value": {
"type": "Anti-Dilutie Inschrijvingsrechten",
"count": "15",
"status": "niet-toegekend",
"issued_date": "27 mei 2025"
},
"object": null,
"subject": "e1"
},
{
"type": "subscription_right_cancellation",
"quote": "De vergadering beslist tot vernietiging van 15.481 inschrijvingsrechten, waarvan (i) 4.372 inschrijvingsrechten werden uitgegeven door de buitengewone algemene vergadering van de Vennootschap van 11 december 2020, (ii) 2.468 inschrijvingsrechten werden uitgegeven door de buitengewone algemene vergadering van de Vennootschap van 27 mei 2025, en (iii) 8.641 inschrijvingsrechten werden uitgegeven door de buitengewone algemene vergadering van de Vennootschap van 5 maart 2026",
"value": {
"type": "ESOP Inschrijvingsrechten",
"count": "15.481",
"status": "niet-toegekend",
"breakdown": [
{
"date": "11 december 2020",
"count": "4.372"
},
{
"date": "27 mei 2025",
"count": "2.468"
},
{
"date": "5 maart 2026",
"count": "8.641"
}
]
},
"object": null,
"subject": "e1"
},
{
"type": "board_authorization",
"quote": "De vergadering beslist met betrekking tot de 2026 BIS ESOP Inschrijvingsrechten uitgegeven in het kader van het \u2018Aandelenoptieplan 2026 BIS\u2019 alle machten te verlenen aan de raad van bestuur teneinde, in overeenstemming met de uitgiftevoorwaarden van voormeld inschrijvingsrechtenplan, de identiteit van de begunstigden vast te stellen en het aantal aan hen aangeboden 2026 BIS ESOP Inschrijvingsrechten en de uitoefenprijs daarvan.",
"value": {
"plan": "Aandelenoptieplan 2026 BIS",
"scope": "vaststelling identiteit begunstigden, aantal aangeboden 2026 BIS ESOP Inschrijvingsrechten en uitoefenprijs",
"mandatary": "raad van bestuur"
},
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 9963,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "1012.800.853",
"kind": "company",
"name": "SPICA THERAPEUTICS",
"attrs": {
"seat": "Uitbreidingstraat 66 bus 3, 2600 Antwerpen",
"legal_form": "Naamloze vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "company",
"name": "Impala Consulting Comm.V",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Alexander Demoulin",
"attrs": {}
},
{
"id": "e4",
"kbo": "0778.398.769",
"kind": "company",
"name": "ALTHUARDE LIFE SCIENCES",
"attrs": {
"seat": "Sint-Niklaasstraat 25, 3321 Hoegaarden",
"legal_form": "besloten vennootschap"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Roderick Verhelst",
"attrs": {
"birth_date": "1985-07-05",
"birth_place": "Leuven"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Tim CARNEWAL",
"attrs": {
"address": "Lloyd Georgelaan 11, 1000 Brussel"
}
}
]
}| Legal nameNL | ALTHUARDE LIFE SCIENCES |